Agilent Technologies Net Profit Margin 2010-2024 | A
Current and historical net profit margin for Agilent Technologies (A) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Agilent Technologies net profit margin for the three months ending July 31, 2024 was .
Agilent Technologies Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2024-07-31 |
$6.50B |
$1.41B |
21.75% |
2024-04-30 |
$6.59B |
$1.24B |
18.84% |
2024-01-31 |
$6.74B |
$1.24B |
18.35% |
2023-10-31 |
$6.83B |
$1.24B |
18.15% |
2023-07-31 |
$6.99B |
$1.13B |
16.20% |
2023-04-30 |
$7.04B |
$1.35B |
19.19% |
2023-01-31 |
$6.93B |
$1.32B |
19.09% |
2022-10-31 |
$6.85B |
$1.25B |
18.31% |
2022-07-31 |
$6.66B |
$1.33B |
19.94% |
2022-04-30 |
$6.53B |
$1.26B |
19.35% |
2022-01-31 |
$6.45B |
$1.21B |
18.70% |
2021-10-31 |
$6.32B |
$1.21B |
19.15% |
2021-07-31 |
$6.14B |
$0.99B |
16.12% |
2021-04-30 |
$5.82B |
$0.93B |
15.90% |
2021-01-31 |
$5.53B |
$0.81B |
14.65% |
2020-10-31 |
$5.34B |
$0.72B |
13.47% |
2020-07-31 |
$5.22B |
$0.69B |
13.23% |
2020-04-30 |
$5.24B |
$0.68B |
13.04% |
2020-01-31 |
$5.24B |
$0.76B |
14.59% |
2019-10-31 |
$5.16B |
$1.07B |
20.74% |
2019-07-31 |
$5.09B |
$1.07B |
21.06% |
2019-04-30 |
$5.02B |
$1.12B |
22.26% |
2019-01-31 |
$4.99B |
$1.14B |
22.86% |
2018-10-31 |
$4.91B |
$0.32B |
6.43% |
2018-07-31 |
$4.81B |
$0.30B |
6.20% |
2018-04-30 |
$4.72B |
$0.24B |
5.02% |
2018-01-31 |
$4.62B |
$0.20B |
4.25% |
2017-10-31 |
$4.47B |
$0.68B |
15.30% |
2017-07-31 |
$4.39B |
$0.63B |
14.41% |
2017-04-30 |
$4.32B |
$0.58B |
13.46% |
2017-01-31 |
$4.24B |
$0.51B |
12.00% |
2016-10-31 |
$4.20B |
$0.46B |
10.99% |
2016-07-31 |
$4.13B |
$0.48B |
11.54% |
2016-04-30 |
$4.10B |
$0.46B |
11.30% |
2016-01-31 |
$4.04B |
$0.46B |
11.36% |
2015-10-31 |
$4.04B |
$0.40B |
9.93% |
2015-07-31 |
$4.81B |
$0.28B |
5.76% |
2015-04-30 |
$4.80B |
$0.31B |
6.52% |
2015-01-31 |
$4.83B |
$0.37B |
7.56% |
2014-10-31 |
$4.81B |
$0.50B |
10.33% |
2014-07-31 |
$4.72B |
$0.69B |
14.65% |
2014-04-30 |
$5.37B |
$0.71B |
13.29% |
2014-01-31 |
$6.11B |
$0.74B |
12.11% |
2013-10-31 |
$6.78B |
$0.72B |
10.68% |
2013-07-31 |
$6.83B |
$0.94B |
13.73% |
2013-04-30 |
$6.90B |
$1.01B |
14.68% |
2013-01-31 |
$6.90B |
$1.10B |
15.96% |
2012-10-31 |
$6.86B |
$1.15B |
16.81% |
2012-07-31 |
$6.82B |
$1.02B |
14.91% |
2012-04-30 |
$6.79B |
$1.10B |
16.27% |
2012-01-31 |
$6.73B |
$1.05B |
15.58% |
2011-10-31 |
$6.62B |
$1.01B |
15.30% |
2011-07-31 |
$6.46B |
$1.02B |
15.70% |
2011-04-30 |
$6.16B |
$0.89B |
14.46% |
2011-01-31 |
$5.75B |
$0.80B |
13.88% |
2010-10-31 |
$5.44B |
$0.68B |
12.56% |
2010-07-31 |
$5.04B |
$0.42B |
8.28% |
2010-04-30 |
$4.71B |
$0.19B |
4.10% |
2010-01-31 |
$4.53B |
$-0.02B |
-0.35% |
2009-10-31 |
$4.48B |
$-0.03B |
-0.69% |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Electrical Test Equipment |
$36.114B |
$6.833B |
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|